| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Fromkin Andrew J. is a Director at IMVT. Recent filings cover 1 purchase and 7 sales. Those positions are worth an estimated $2.1M at current prices.
Our model assigns Fromkin Andrew J. a below-average insider score of 45/100, based on 4 past trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -11.7%.
Fromkin Andrew J.'s largest disclosed position is in IMVT as Director, worth about $2.1M. The recent filings there lean toward selling, a net 37,099 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | IMVT Immunovant, Inc. | Director | Sell | 22,249 | $23.25 | $517,189.24 | -20.6% | +22.0% | - | |
| Mar 7, 2025 | IMVT Immunovant, Inc. | Director | Sell | 8,000 | $19.60 | $156,768.96 | -8.0% | -20.0% | +33.2% | |
| Dec 1, 2023 | IMVT Immunovant, Inc. | Director | Sell | 12,350 | $39.73 | $490,696.72 | -12.2% | -12.8% | -30.5% | |
| Aug 10, 2021 | IMVT Immunovant, Inc. | Director | Buy | 5,500 | $7.90 | $43,450.00 | +13.7% | +9.0% | -32.5% |